
Thomas C. Mckenzie
Examiner (ID: 6300)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1625, 1624, 1611 |
| Total Applications | 744 |
| Issued Applications | 514 |
| Pending Applications | 94 |
| Abandoned Applications | 135 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6697508
[patent_doc_number] => 20030109702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Pyrazolyl benzyl ethers'
[patent_app_type] => new
[patent_app_number] => 10/149237
[patent_app_country] => US
[patent_app_date] => 2002-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10113
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0109/20030109702.pdf
[firstpage_image] =>[orig_patent_app_number] => 10149237
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/149237 | Pyrazolyl benzyl ethers | Jun 6, 2002 | Abandoned |
Array
(
[id] => 6874922
[patent_doc_number] => 20030195219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-16
[patent_title] => 'Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering cns activity'
[patent_app_type] => new
[patent_app_number] => 10/344285
[patent_app_country] => US
[patent_app_date] => 2003-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14346
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0195/20030195219.pdf
[firstpage_image] =>[orig_patent_app_number] => 10344285
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/344285 | Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering CNS activity | Jun 6, 2002 | Issued |
Array
(
[id] => 6688940
[patent_doc_number] => 20030032665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Method of inhibiting matrix metalloproteinases'
[patent_app_type] => new
[patent_app_number] => 10/162518
[patent_app_country] => US
[patent_app_date] => 2002-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10574
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20030032665.pdf
[firstpage_image] =>[orig_patent_app_number] => 10162518
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/162518 | Method of inhibiting matrix metalloproteinases | Jun 3, 2002 | Issued |
| 10/009559 | Receptor agonists and antagonists | Jun 3, 2002 | Abandoned |
Array
(
[id] => 6683963
[patent_doc_number] => 20030119827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Novel nitriles useful as reversible inhibitors of cysteine proteases'
[patent_app_type] => new
[patent_app_number] => 10/163015
[patent_app_country] => US
[patent_app_date] => 2002-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26222
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119827.pdf
[firstpage_image] =>[orig_patent_app_number] => 10163015
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/163015 | Nitriles useful as reversible inhibitors of cysteine proteases | Jun 3, 2002 | Issued |
Array
(
[id] => 1022075
[patent_doc_number] => 06887997
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-03
[patent_title] => '9H-imidazo[1,2-a]purin-9-one compounds'
[patent_app_type] => utility
[patent_app_number] => 10/161215
[patent_app_country] => US
[patent_app_date] => 2002-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5288
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/887/06887997.pdf
[firstpage_image] =>[orig_patent_app_number] => 10161215
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/161215 | 9H-imidazo[1,2-a]purin-9-one compounds | May 30, 2002 | Issued |
Array
(
[id] => 1156836
[patent_doc_number] => 06762171
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-07-13
[patent_title] => 'Fatty acid CoA thioester inhibitory substance of PPAR and PPAR '
[patent_app_type] => B1
[patent_app_number] => 10/070439
[patent_app_country] => US
[patent_app_date] => 2002-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2039
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/762/06762171.pdf
[firstpage_image] =>[orig_patent_app_number] => 10070439
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/070439 | Fatty acid CoA thioester inhibitory substance of PPAR and PPAR | May 29, 2002 | Issued |
Array
(
[id] => 6761974
[patent_doc_number] => 20030125336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Hydrohalide salts of an HIV protease inhibitor'
[patent_app_type] => new
[patent_app_number] => 10/158630
[patent_app_country] => US
[patent_app_date] => 2002-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18340
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20030125336.pdf
[firstpage_image] =>[orig_patent_app_number] => 10158630
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/158630 | Hydrohalide salts of an HIV protease inhibitor | May 29, 2002 | Abandoned |
Array
(
[id] => 6774861
[patent_doc_number] => 20030018199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/158355
[patent_app_country] => US
[patent_app_date] => 2002-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11626
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20030018199.pdf
[firstpage_image] =>[orig_patent_app_number] => 10158355
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/158355 | Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors | May 29, 2002 | Issued |
Array
(
[id] => 1248454
[patent_doc_number] => 06673795
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-01-06
[patent_title] => 'Pyrimidine, pyrazine and triazane derivatives'
[patent_app_type] => B2
[patent_app_number] => 10/157338
[patent_app_country] => US
[patent_app_date] => 2002-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21996
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/673/06673795.pdf
[firstpage_image] =>[orig_patent_app_number] => 10157338
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/157338 | Pyrimidine, pyrazine and triazane derivatives | May 28, 2002 | Issued |
Array
(
[id] => 6330154
[patent_doc_number] => 20020198252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-26
[patent_title] => 'Process for the preparation of alkylamine substituted indoles'
[patent_app_type] => new
[patent_app_number] => 10/153357
[patent_app_country] => US
[patent_app_date] => 2002-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7180
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20020198252.pdf
[firstpage_image] =>[orig_patent_app_number] => 10153357
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/153357 | Process for the preparation of alkylamine substituted indoles | May 21, 2002 | Abandoned |
Array
(
[id] => 6683980
[patent_doc_number] => 20030119844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => '2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines'
[patent_app_type] => new
[patent_app_number] => 10/154482
[patent_app_country] => US
[patent_app_date] => 2002-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22831
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119844.pdf
[firstpage_image] =>[orig_patent_app_number] => 10154482
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/154482 | 2,5-diarypyrimidine compounds | May 21, 2002 | Issued |
Array
(
[id] => 6159613
[patent_doc_number] => 20020147339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => '5-cyano-2-aminopyrimidine derivatives'
[patent_app_type] => new
[patent_app_number] => 10/151518
[patent_app_country] => US
[patent_app_date] => 2002-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31757
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20020147339.pdf
[firstpage_image] =>[orig_patent_app_number] => 10151518
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/151518 | 5-cyano-2-aminopyrimidine derivatives | May 19, 2002 | Abandoned |
| 10/031696 | Novel juvenile hormone analogues and their use as antifouling agents | May 15, 2002 | Abandoned |
Array
(
[id] => 6112814
[patent_doc_number] => 20020173512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-21
[patent_title] => 'Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use'
[patent_app_type] => new
[patent_app_number] => 10/147950
[patent_app_country] => US
[patent_app_date] => 2002-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11102
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20020173512.pdf
[firstpage_image] =>[orig_patent_app_number] => 10147950
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/147950 | Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use | May 15, 2002 | Abandoned |
Array
(
[id] => 6756554
[patent_doc_number] => 20030004331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-02
[patent_title] => 'Method for purifying 5\' -protected thymidines and novel derivatives thereof'
[patent_app_type] => new
[patent_app_number] => 10/144802
[patent_app_country] => US
[patent_app_date] => 2002-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4382
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20030004331.pdf
[firstpage_image] =>[orig_patent_app_number] => 10144802
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/144802 | Method for purifying 5′ -protected thymidines and novel derivatives thereof | May 14, 2002 | Issued |
Array
(
[id] => 1034554
[patent_doc_number] => 06875765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-04-05
[patent_title] => 'Arylsulfonamide ethers, and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/143675
[patent_app_country] => US
[patent_app_date] => 2002-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 61523
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/875/06875765.pdf
[firstpage_image] =>[orig_patent_app_number] => 10143675
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/143675 | Arylsulfonamide ethers, and methods of use thereof | May 9, 2002 | Issued |
Array
(
[id] => 1059627
[patent_doc_number] => 06852717
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-02-08
[patent_title] => 'Compounds useful as anti-inflammatory agents'
[patent_app_type] => utility
[patent_app_number] => 10/143322
[patent_app_country] => US
[patent_app_date] => 2002-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12243
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/852/06852717.pdf
[firstpage_image] =>[orig_patent_app_number] => 10143322
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/143322 | Compounds useful as anti-inflammatory agents | May 9, 2002 | Issued |
Array
(
[id] => 6861690
[patent_doc_number] => 20030092698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa'
[patent_app_type] => new
[patent_app_number] => 10/143190
[patent_app_country] => US
[patent_app_date] => 2002-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25480
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20030092698.pdf
[firstpage_image] =>[orig_patent_app_number] => 10143190
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/143190 | N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa | May 9, 2002 | Abandoned |
Array
(
[id] => 1166504
[patent_doc_number] => 06756376
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-06-29
[patent_title] => 'Tricyclic azaindolizine derivatives having an sPLA2-inhibitory activities'
[patent_app_type] => B1
[patent_app_number] => 10/129658
[patent_app_country] => US
[patent_app_date] => 2002-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14776
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/756/06756376.pdf
[firstpage_image] =>[orig_patent_app_number] => 10129658
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/129658 | Tricyclic azaindolizine derivatives having an sPLA2-inhibitory activities | May 8, 2002 | Issued |